Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR) Spiked Up 1.4% – Here’s Why

For its latest trading sesion, Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR) spiked up by 1.4% – here is what that looked like (as of 2019-12-24):

What’s the reason for these moves? To grasp this action better, We ought to analyze some technical indicators. The most interesting and telling are these ones:

A Money Flow Index (MFI) of 100.0, a Relative Strength Index (RSI) of 50.0, a True Strength Index (TSI) of 100.0, a Moving Average Convergence Divergence (MACD) of -0.013, an Average Directional Movement Index (ADX) of unknown, an Average True Range (ATR) of 0.203, an Accumulation/Distribution Index (ADI) of 0.203, an On-Balance Volume (OBV) of 55.365, and a Chaiikin Money Flow (CMF) of -24.03. 1.286

Now let’s take all these indicators into account. According to Trading View, putting it all together gets the following:

So there you have it – our analysis of Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR). Note this is technical analysis only! You should do fundamental research as well, and do not just rely on this – we take no responsibility for any losses incurred if you buy or sell based on the above.